Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.94 - $5.23 $90,846 - $161,607
-30,900 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.07 - $10.6 $125,763 - $327,540
30,900 New
30,900 $150,000
Q2 2021

Aug 16, 2021

SELL
$18.04 - $22.09 $377,288 - $461,990
-20,914 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$16.59 - $33.89 $1.87 Million - $3.81 Million
-112,465 Reduced 84.32%
20,914 $631,000
Q4 2020

Feb 16, 2021

SELL
$27.5 - $37.92 $1.1 Million - $1.52 Million
-40,082 Reduced 23.11%
133,379 $5.77 Million
Q3 2020

Nov 16, 2020

BUY
$34.44 - $43.75 $3.13 Million - $3.98 Million
90,876 Added 110.04%
173,461 $9.36 Million
Q2 2020

Aug 14, 2020

BUY
$27.12 - $45.97 $2.24 Million - $3.8 Million
82,585 New
82,585 $5.04 Million
Q2 2019

Aug 14, 2019

SELL
$75.84 - $105.21 $582,527 - $808,118
-7,681 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$64.44 - $104.11 $494,963 - $799,668
7,681 New
7,681 $1.21 Million
Q4 2018

Feb 14, 2019

SELL
$59.1 - $93.26 $361,041 - $569,725
-6,109 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.86 - $117.49 $265,602 - $351,177
2,989 Added 95.8%
6,109 $891,000
Q2 2018

Aug 14, 2018

SELL
$99.64 - $127.59 $3.06 Million - $3.92 Million
-30,726 Reduced 90.78%
3,120 $489,000
Q1 2018

May 15, 2018

BUY
$105.8 - $150.94 $3.58 Million - $5.11 Million
33,846 New
33,846 $5.78 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $708M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.